Maternal periconceptional alcohol consumption and risk for orofacial clefts - 08/09/11
Abstract |
Objective: To investigate whether periconceptional maternal alcohol consumption increased the risk of delivering infants with orofacial cleft phenotypes. Design: Data were derived from a large population-based case control study of fetuses and infants among a cohort of California births from 1987 to 1989 (n = 548,844). Information concerning alcohol consumption was obtained by telephone interviews with mothers of 731 infants (84.7% of eligible) with orofacial clefts and of 734 (78.2%) infants in a nonmalformed control group. Results: Thirty-nine percent of mothers in the case group and 42% of mothers in the control group reported that they consumed alcohol during the period 1 month before through 3 months after conception. Relative to nonconsumers, women who reported alcohol consumption (<weekly, weekly, or daily) were not at substantially increased risk of delivering infants with any cleft phenotype. However, for women who reported weekly or more frequent episodes of consuming ≥5 drinks per drinking occasion compared with those who did not, we observed increased risks for isolated (no other major congenital anomaly) cleft lip with or without cleft palate, odds ratio = 3.4 (95% confidence interval, 1.1 to 9.7); multiple cleft lip with or without cleft palate, odds ratio = 4.6 (1.2 to 18.8); and “known syndrome” clefts, odds ratio = 6.9 (1.9 to 28.6). Adjustment for maternal cigarette smoking, race, education, or vitamin use did not substantially change observed risks. Conclusion: We observed a lack of increased risks of clefts for relatively low quantities of maternal alcohol consumption and increased risks of clefts for higher quantities of maternal alcohol consumption. (J Pediatr 1999;134:298-303)
Le texte complet de cet article est disponible en PDF.Abbreviations : CLP, CP, FAS
Plan
| Partially supported by the Cigarette and Tobacco Surtax Fund of California Tobacco-Related Disease Research Program, University of California, 1RT466 and 3RT0413. |
|
| Reprint requests: Gary M. Shaw, California Birth Defects Monitoring Program, 1900 Powell St, Suite 1050, Emeryville, CA 94608. |
|
| 0022-3476/99/$8.00 + 0 9/21/96099 |
Vol 134 - N° 3
P. 298-303 - mars 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
